The role of 18F-FDG PET/CT imaging in the diagnosis of ovarian cancer
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Jan-Feb;38(1):50-51.
doi: 10.1016/j.remn.2018.08.003.
Epub 2018 Nov 1.
[Article in
English,
Spanish]
Affiliations
- 1 Nuclear Medicine & PET Unit, Department of Molecular Imaging, Nuclear Medicine, Radiology, NeuroRadiology and Clinical Pathology, Rovigo Hospital, Rovigo, Italy. Electronic address: domenico.rubello@aulss5.veneto.it.
- 2 Nuclear Medicine & PET Unit, Department of Molecular Imaging, Nuclear Medicine, Radiology, NeuroRadiology and Clinical Pathology, Rovigo Hospital, Rovigo, Italy.
- 3 Department of Nuclear Medicine, University of Southern California, Los Angeles, EE.UU.
No abstract available
MeSH terms
-
Female
-
Fluorodeoxyglucose F18*
-
Humans
-
Ovarian Neoplasms / diagnostic imaging*
-
Positron Emission Tomography Computed Tomography* / methods
-
Radiopharmaceuticals*
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18